Literature DB >> 27918913

Reduced cortical thickness in body dysmorphic disorder.

Sally A Grace1, Ben G Buchanan2, Jerome J Maller3, Wei Lin Toh3, David J Castle4, Susan L Rossell5.   

Abstract

Recent neuroimaging studies in body dysmorphic disorder (BDD) have implicated abnormal structure and function of occipito-temporal and fronto-limbic regions in the potential pathophysiology of the disorder. To date, morphometric investigations have yielded inconsistent results, and have suggested that clinical symptoms may mediate structural brain abnormalities in BDD. We measured Grey Matter (GM) cortical thickness in 20 participants with BDD and 20 healthy control participants matched on age, gender, estimated IQ and handedness. We observed cortical thinning in BDD patients compared with healthy control participants within the left middle temporal and left inferior parietal gyrus. No significant relationships between cortical thickness and BDD symptom severity, insight, social anxiety and depression were observed within the BDD group. Thinning within left temporal and left inferior parietal regions supports the involvement of these regions in the pathophysiology of BDD.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Cerebral cortex; Grey matter; Magnetic resonance imaging; Psychiatry

Mesh:

Year:  2016        PMID: 27918913     DOI: 10.1016/j.pscychresns.2016.11.004

Source DB:  PubMed          Journal:  Psychiatry Res Neuroimaging        ISSN: 0925-4927            Impact factor:   2.376


  4 in total

1.  Cytoarchitectonically Defined Volumes of Early Extrastriate Visual Cortex in Unmedicated Adults With Body Dysmorphic Disorder.

Authors:  Jamie D Feusner; Florian Kurth; Eileen Luders; Ronald Ly; Wan-Wa Wong
Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging       Date:  2021-10-21

Review 2.  [Body dysmorphic disorder : Diagnostics and treatment in cosmetic dermatology].

Authors:  T Lahousen; D Linder; T Gieler; U Gieler
Journal:  Hautarzt       Date:  2017-12       Impact factor: 0.751

Review 3.  Pharmacological Treatment of Body Dysmorphic Disorder.

Authors:  Kevin Hong; Vera Nezgovorova; Genoveva Uzunova; Danya Schlussel; Eric Hollander
Journal:  Curr Neuropharmacol       Date:  2019       Impact factor: 7.363

4.  A phenomenological exploration of self-identified origins and experiences of body dysmorphic disorder.

Authors:  Shioma-Lei Craythorne; Rachel L Shaw; Michael Larkin
Journal:  Front Psychol       Date:  2022-09-23
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.